Pre-ESRD Syndrome in High Risk African Americans

This study has been terminated.
(Only apx 1/3 of enrolled subjects (signed consent) participated. Futility analysis to show primary endpoint)
Sponsor:
Information provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:
NCT00224939
First received: September 21, 2005
Last updated: January 12, 2010
Last verified: January 2010
  Purpose

Evaluation of the dipping status of blood pressure (wether blood pressure decreases at night) and renal functional reserve and wether non-dippers (those whose blood pressure does not decrease at night) can be modulated to dippers with potassium treatment.


Condition Intervention
Blood Pressure
Drug: Potassium Chloride

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Prevention
Official Title: Pre-ESRD Syndrome in High Risk African American Young Adults

Resource links provided by NLM:


Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Estimated Enrollment: 144
Study Start Date: July 2002
Study Completion Date: December 2006
Detailed Description:

Evaluation of the dipping status of blood pressure (wether blood pressure decreases at night) and renal functional reserve and wether non-dippers (those whose blood pressure does not decrease at night) can be modulated to dippers with potassium treatment.

  Eligibility

Ages Eligible for Study:   18 Years to 35 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria: 18-35, healthy volunteers, African American

Exclusion Criteria: Active medical conditions, prescription drug therapy other than birth control

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00224939

Locations
United States, Virginia
Virginia Commonwealth University
Richmond, Virginia, United States, 23298
Sponsors and Collaborators
Investigators
Principal Investigator: Elizabeth B Ripley, MD Virginia Commonwealth University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00224939     History of Changes
Other Study ID Numbers: DK 62714 (terminated)
Study First Received: September 21, 2005
Last Updated: January 12, 2010
Health Authority: United States: Federal Government

ClinicalTrials.gov processed this record on October 19, 2014